carbon nanoparticle-iron complex (Chongqing LUMMY Pharmaceutical)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namecarbon nanoparticle-iron complex (Chongqing LUMMY Pharmaceutical)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetastatic breast cancerVulvar Intraepithelial NeoplasiaKidney Neoplasms +[14] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChongqing Lummy Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChongqing Lummy Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancerVulvar Intraepithelial NeoplasiaKidney Neoplasms +[13] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A